阿里达摩院多癌早筛AI全球推广，已服务9个国家地区2000万人次

Core Insights - The core focus of the news is on Alibaba's Damo Academy showcasing its multi-cancer early screening AI technology at the AI for Good Global Summit, emphasizing its global reach and impact in cancer detection [1][2]. Group 1: Technology and Innovation - The multi-cancer early screening AI technology has been implemented in 9 countries and regions, serving 20 million people, positioning AI as a crucial tool in combating cancer [1]. - The technology utilizes a "plain scan CT + AI" approach, leveraging widely used plain scan CT images to identify lesions that are often overlooked by human eyes [1]. - The research has been published in top-tier journals and has received "breakthrough medical device designation" from the FDA [1]. Group 2: Case Studies and Impact - A case was highlighted where a 33-year-old patient was diagnosed with pancreatic cancer through AI analysis of a chest CT scan, demonstrating the potential for early intervention and cure [2]. - Another case involved a tumor with a malignant portion measuring only 1 millimeter, underscoring the effectiveness of AI in early cancer detection [2]. Group 3: Global Collaborations - Damo Academy has formed partnerships with healthcare institutions in Singapore and Saudi Arabia to enhance early screening capabilities for various cancers and chronic diseases [5]. - In Singapore, collaboration with NHG Health aims to improve early detection of pancreatic cancer, breast cancer, and other conditions through joint research and validation [5]. - In Saudi Arabia, a partnership with Abdul Latif Jameel Health will explore AI-assisted diagnosis for multiple cancers and chronic diseases, making advanced medical services accessible in developing regions [5].